General
Preferred name
cinnamaldehyde
Synonyms
Cinnamic aldehyde ()
Cinnamal ()
Phenylacrolein ()
trans-Cinnamaldehyde ()
.beta.-phenylacrolein ()
Zimtaldehyde ()
XC-800 ()
FEMA NO. 2286 ()
NSC-40346 ()
Cinnamic Aldehyde ()
Abion ca ()
NSC-16935 ()
P&D ID
PD046487
CAS
104-55-2
14371-10-9
Tags
available
covalent binder
drug
Drug indication
Discovery agent
Drug Status
approved
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
trans-Cinnamaldehyde can be used to prepare highly polyfunctionalized furan ring by reaction of alkyl isocyanides with dialkyl acetylenedicarboxylate[1]. trans-Cinnamaldehyde can be used to synthesize trans-cinnamaldehyde -¦Â-cyclodextrin complex, an antimicrobial edible coating that increases the shelf life of fresh-cut fruits[2].
PRICE
1100
DESCRIPTION
Cinnamaldehyde is a naturally occurring flavonoid. It is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
(Enamine Bioactive Compounds)
DESCRIPTION
1. trans-Cinnamaldehyde (Phenylacrolein) exhibits excellent anti-inflammatory activities and antidepressant-like effects in stressed mid-aged rats as a COX-2 inhibitor. 2. Cinnamic aldehyde induces apoptosis of CML cells in vitro, down-regulation of the expression and function of BCR-ABL may be one of its most important anti-leukemia mechanisms. 3. Cinnamic aldehyde and cinnamic acid are cardioprotective in a rat model of ischemic myocardial injury, the mechanism is related to anti-oxidative and anti-inflammatory properties.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
1
Compound Sets
19
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CovBinderInPDB
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugMAP
Enamine Bioactive Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
72
Molecular Weight
132.06
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
0
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
1.9
TPSA
17.07
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.44
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
TRP Channel
COX-2
Endogenous Metabolite
TRPA1
Environmental Pollutants
MOA
COX
TRPA1 Agonists
Aldose Reductase Inhibitors
aldose reductase inhibitor, TRPV agonist
Member status
virtual
Pathway
Metabolic Enzyme/Protease
Immunology/Inflammation
Membrane Transporter/Ion Channel
Metabolism
Neuroscience
Source data

